Aclarion, Inc. SEC filings ACONW
Aclarion, Inc. has 276 filings in SEC EDGAR's recent list, going back to Mar 3, 2015. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jun 4, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-A12B | Form 8-a12b | Mar 19, 2026 | — |
| EFFECT | Filing | May 5, 2025 | — |
| CORRESP | Letter to the SEC | Apr 30, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2025 | — |
| NT 10-K | Filing | Mar 31, 2025 | Dec 31, 2024 |
| EFFECT | Filing | Jan 14, 2025 | — |
| CORRESP | Letter to the SEC | Jan 10, 2025 | — |
| CORRESP | Letter to the SEC | Jan 10, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| CORRESP | Letter to the SEC | Nov 7, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2024 | — |
| EFFECT | Filing | Nov 4, 2024 | — |
| CORRESP | Letter to the SEC | Nov 1, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2024 | — |
| EFFECT | Filing | Oct 24, 2024 | — |
| CORRESP | Letter to the SEC | Oct 18, 2024 | — |
| D | Filing | Oct 15, 2024 | — |
| EFFECT | Filing | Sep 23, 2024 | — |
| CORRESP | Letter to the SEC | Sep 20, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2024 | — |
| 253G3 | Form 253g | Aug 13, 2024 | — |
| QUALIF | Filing | Jun 24, 2024 | — |
| CORRESP | Letter to the SEC | Jun 20, 2024 | — |
| 1-A/A | Filing | Jun 20, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2024 | — |
| 1-A | Filing | Jun 11, 2024 | — |
| EFFECT | Filing | Feb 26, 2024 | — |
| CORRESP | Letter to the SEC | Feb 23, 2024 | — |
| CORRESP | Letter to the SEC | Feb 23, 2024 | — |
| EFFECT | Filing | Feb 1, 2024 | — |
| CORRESP | Letter to the SEC | Feb 1, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2023 | — |
| EFFECT | Filing | Oct 20, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2023 | — |
| CORRESP | Letter to the SEC | Oct 18, 2023 | — |
| NT 10-Q | Filing | Aug 14, 2023 | Jun 30, 2023 |
| EFFECT | Filing | Jul 14, 2023 | — |
| CORRESP | Letter to the SEC | Jul 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 11, 2023 | — |
| D | Filing | May 31, 2023 | — |
| NT 10-Q | Filing | May 16, 2023 | Mar 31, 2023 |
| EFFECT | Filing | Apr 21, 2022 | — |
| CERT | Filing | Apr 21, 2022 | — |
| 8-A12B | Form 8-a12b | Apr 20, 2022 | — |
| CORRESP | Letter to the SEC | Apr 20, 2022 | — |
| CORRESP | Letter to the SEC | Apr 20, 2022 | — |
| CORRESP | Letter to the SEC | Apr 20, 2022 | — |
| CORRESP | Letter to the SEC | Apr 1, 2022 | — |
| CORRESP | Letter to the SEC | Mar 23, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2022 | — |
| CORRESP | Letter to the SEC | Mar 4, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2022 | — |
| CORRESP | Letter to the SEC | Jan 5, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2021 | — |
| D | Filing | Oct 26, 2021 | — |
| DRS | Filing | Oct 25, 2021 | — |
| D | Filing | Mar 12, 2020 | — |
| D/A | Filing | May 15, 2018 | — |
| D | Filing | Aug 11, 2017 | — |
| D | Filing | Mar 3, 2015 | — |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- ACON (Nasdaq), ACONW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Broomfield, CO
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1635077
- Former names
- Nocimed, Inc. (until Oct 26, 2021)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.